ResearcherIuliu Hațieganu University of Medicine and PharmacyActive in the last 2 years
Cristina Adela Iuga
Matched on ORCID iD 0000-0002-0345-0993; OpenAlex author ID A5002657397, A5029560113. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- Discovery of a Secretory Granule Lumen-Enriched Serum Protein Signature in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/medicina62030605↗
- Proteomic Profiling of EUS-FNA Samples Differentiates Pancreatic Adenocarcinoma from Mass-Forming Chronic Pancreatitis. Last author DOI 10.3390/biomedicines13092199↗
- Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes. Co-author DOI 10.26355/eurrev_202202_28127↗
- Serum JAK/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients. Co-author DOI 10.14715/cmb/2021.67.3.14↗
- Plasma protein profiling of patients with intraductal papillary mucinous neoplasm of the pancreas as potential precursor lesions of pancreatic cancer. Co-author DOI 10.1016/j.cca.2017.12.008↗
- Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/pmic.201300402↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrada Seicean · 5 shared papers, 2014–2026 · strength 0.89
- Paper Proteomic Profiling of EUS-FNA Samples Differentiates Pancreatic Adenocarcinoma from Mass-Forming Chronic Pancreatitis. DOI 10.3390/biomedicines13092199↗
- Paper Discovery of a Secretory Granule Lumen-Enriched Serum Protein Signature in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/medicina62030605↗
- Paper Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes. DOI 10.26355/eurrev_202202_28127↗
- Maria Ilies · 3 shared papers, 2018–2022 · strength 0.39
- Paper Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes. DOI 10.26355/eurrev_202202_28127↗
- Paper Serum JAK/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients. DOI 10.14715/cmb/2021.67.3.14↗
- Paper Plasma protein profiling of patients with intraductal papillary mucinous neoplasm of the pancreas as potential precurso… DOI 10.1016/j.cca.2017.12.008↗
- Livia Petrusel · 2 shared papers, 2021–2022 · strength 0.31
- Radu Seicean · 2 shared papers, 2021–2022 · strength 0.31
- Casandra Teodorescu · 1 shared paper, 2025 · strength 0.28
- Nadim Al Hajjar · 1 shared paper, 2026 · strength 0.25
- Emil Ioan Moiș · 1 shared paper, 2026 · strength 0.25
- Septimiu Alex Moldovan · 1 shared paper, 2026 · strength 0.25
- T Man · 1 shared paper, 2022 · strength 0.16
- Elke Hammer · 2 shared papers, 2014–2018 · strength 0.12
- Frank Ulrich Weiß · 1 shared paper, 2018 · strength 0.08
- Georg Beyer · 1 shared paper, 2018 · strength 0.08
- Julia V. Mayerle · 1 shared paper, 2018 · strength 0.08
- Markus M. Lerch · 1 shared paper, 2018 · strength 0.08
- Cornel Iancu · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.